• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

Cardiac safety is the #1 reason for drug development failure & post-market recalls.

High-quality data and reporting are essential to drive decisions during the entire study cycle from Phase I to Phase IV. As the most trusted name in cardiac safety with 50 years of experience, Clario uses a centralized approach to collection and our data tools are rigorous, responsive, and reliable. 

Our goal is always to

  • Improve patient safety and enrollment
  • Increase data access leading to reduced timelines 
  • Deliver scientific-grade data to reduce variability
  • Solutions with the patients in mind

Regardless of therapeutic area, Clario has mastered collecting reliable evidence needed to bring new drugs and therapies to market. Learn how our solutions and scientific expertise can help you effectively plan, expertly design, efficiently implement and successfully deliver the cardiac safety data for your submission.

Proven results earn trust

13,887

Trials supported

580

New drug approvals

50

Years science

600+

QT studies

200+

Combined years of clinical experience

480+

Unique programs

87+

Approvals from TQTS alone

230+

Sponsors

Cardiac Safety Science Team

Robert Kleiman headshot

Robert Kleiman, MD

VP, Cardiology & Chief Medical Officer

Todd Rudo headshot

Todd Rudo, MD

VP, Cardiology & Deputy Chief Medical Officer

Borje Darpo headshot

Borje Darpo, MD, PhD

Chief Scientific Advisor

Jeff Morganroth headshot

Joel Morganroth, MD

Chief Scientific Advisor

Mori Krantz headshot

Mori J. Krantz, MD, FACP, FACC

Chief Science Advisor, Cardiovascular Imaging, Senior Cardiologist, Global Cardiac Safety

Bruce Lloyd headshot

Bruce Lloyd, MD

Medical Director

Onglee Weng headshot

Onglee Weng, MBA, MD

Director, Medical & Scientific Affairs

Jean T Barbey headshot

Jean T. Barbey, MD

Expert Cardiac Safety Medical Advisor

Jeff Heilbraun headshot

Jeff Heilbraun, MS

VP Medical Affairs, Cardiac Safety

Luc Dekie headshot

Luc Dekie, PhD

Director, Scientific Affairs

Increase confidence in site performance with Clario Certified Sites.

Clario Certified Sites have completed our Certified Site program to ensure that each study is conducted in an optimal manner and results in the highest quality data. The certification program requires each site to go through an extensive training and testing process. These sites help sponsors reduce study start-up time with well-trained and well-equipped sites.

Related Therapeutic Areas

Learn more or speak with one of our experts

Our team of clinical trial cardiac safety experts are always available to address questions about our cardiac safety solutions. Submit your contact information and we’ll be in touch shortly.